SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · MED

Normative trajectories of R <sub>1</sub> , R <sub>2</sub> *, and magnetic susceptibility in basal ganglia on healthy ageing.

Imaging Neurosci (Camb) · 2025-02-03

DOI: 10.1162/imag_a_00456PMID: 40800912

Open accessresearch-article; Journal ArticleOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

Quantitative MRI (qMRI) techniques, including R1, R2*, and magnetic susceptibility mapping, have emerged as promising tools for generating surrogate imaging markers of brain tissue microstructure, enabling non-invasive in vivo measurements associated with myelination and iron deposition. Gaining insights into how these quantitative measurements evolve throughout a normal lifespan can enhance our understanding of brain maturation processes and facilitate studies of disease-related microstructural changes by distinguishing pathological alterations from normal brain development. In this study, we established the normative trajectories of R1, R2*, and magnetic susceptibility in the basal ganglia at 3T. We used a healthy ageing cohort comprising 260 subjects with an evenly distributed age range (from 18 to 80 years) and sex ratio throughout adulthood. Utilising the non-parametric Gaussian Process Regression model to derive the normative trajectories, we found that R1in these structures predominantly exhibits a quadratic shape over age, while R2* and magnetic susceptibility are primarily linear. We validated the normative trajectories of R2* and magnetic susceptibility using an independent cohort. This result reinforces existing findings on the association between age and qMRI. Additionally, we demonstrated that the spatial distributions of the qMRI parameters also change with age in the putamen and caudate nucleus. Finally, the utility of normative modelling of qMRI in the basal ganglia is validated using an independent cohort comprising both healthy participants and individuals with Parkinson's disease, with comparable data acquisition protocols.

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.